TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes September 10, 1999
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture August 14, 1998
TCL Archive Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival August 31, 2012
